BiotechTubeBiotechTube
Home/Apogee Therapeutics/Tomas Kiselak
TK

Tomas Kiselak

Founding Partner, Fairmount Funds Management LLC (Board)

Apogee Therapeutics

Roles

Founding Partner, Fairmount Funds Management LLC (Board)atApogee Therapeutics
Board of DirectorsatSpyre Therapeutics
Board of DirectorsatZenas BioPharma

Therapeutic Areas

DermatologyPulmonologyGastroenterologyImmunology

Apogee Therapeutics Pipeline

DrugIndicationPhase
Zumilokibart (APG777)Moderate-to-Severe Atopic DermatitisPhase 2
APG279 (Zumilokibart + APG990)Moderate-to-Severe Atopic DermatitisPhase 1
APG273 (Zumilokibart + APG333)Asthma / COPDPreclinical
APG333Respiratory & Broader I&I ConditionsPhase 1
APG808Asthma (Type 2 Allergic Diseases)Phase 1b

Leadership Team at Apogee Therapeutics

MH
Michael Henderson, MD
Chief Executive Officer
CD
Carl Dambkowski, MD
Chief Medical Officer
JP
Jane Pritchett Henderson
Chief Financial Officer
RD
Rebecca Dabora, PhD
Chief Development Officer
MB
Matt Batters, JD
Chief Legal Officer
JH
Jeff Hartness
Chief Commercial Officer
DM
Dan Mulreany
Chief Business Officer
EC
Emily Cox
SVP, Head of People
MC
Mark C. McKenna
Chairman and Chief Executive Officer, Mirador Therapeutics (Board)
LB
Lisa Bollinger, MD
Chief Executive Officer and President of Bollinger Regulatory Consulting (BRC), LLC (Board)
View full Apogee Therapeutics profile